The complex challenges of HIV vaccine development require renewed and expanded global commitment

The Lancet
Feb 01, 2020 Volume 395Number 10221p311-388, e16-e18
https://www.thelancet.com/journals/lancet/issue/current

 

Viewpoint
The complex challenges of HIV vaccine development require renewed and expanded global commitment
Linda-Gail Bekker, er al
Despite substantial progress in understanding and treating HIV/AIDS, existing tools have not effectively controlled the epidemic, and the potential threat of resurgence looms as the largest cohort of young people in history enters early adulthood. 1 Treatment alone will not end the epidemic. 234 The International AIDS Society – Lancet Commission 1 recommends that global treatment efforts should be complemented with stronger investments in primary prevention, including research to accelerate the development of a preventive vaccine. Indeed, even a partially effective vaccine could help to change the course of the HIV epidemic and have a substantial public health impact. 5678